drugset / Trial / NCT02430558

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft

NCT02430558 ↗

Phase 1/2 Terminated 10 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

Patient with IKDC score \< 65, pretreated with mosaicplasty or ACI ( with matrix or not) within \> 18 months, with one or two osteochondral lesions are recruited to have treated osteochondral allografts in mosaicplasty.

Timeline

Start
2016-04-05
Primary completion
2021-06-15
Completion
2021-06-15

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual rate”

Drugs

EvaluationDrugModalityDoseRoute
Subject OD-PHOENIX Other / unclassified — —